Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry
Journal of Virology · 2024
DOI: 10.1128/jvi.01957-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Zihui Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Alphacoronavirus, Virus Internalization, Virus Replication. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), | Beijing Municipal Natural Science Foundation ().
Abstract (Originalsprache)
Zoonotic coronaviruses pose a continuous threat to human health, with newly identified bat-borne viruses like swine acute diarrhea syndrome coronavirus (SADS-CoV) causing high mortality in piglets. In vitro studies indicate that SADS-CoV can infect cell lines from diverse species, including humans, highlighting its potential risk to human health. However, the lack of tools to study viral entry, along with the absence of vaccines or antiviral therapies, perpetuates this threat. To address this, we engineered an infectious molecular clone of Vesicular Stomatitis Virus (VSV), replacing its native glycoprotein (G) with SADS-CoV spike (S) and inserting a Venus reporter at the 3′ leader region to generate a replication-competent rVSV-Venus-SADS S virus. Serial passages of rVSV-Venus-SADS S led to the identification of an 11-amino-acid truncation in the cytoplasmic tail of the S protein, which allowed more efficient viral propagation due to increased cell membrane anchoring of the S protein. The S protein was integrated into rVSV-Venus-SADS SΔ11 particles, susceptible to neutralization by sera from SADS-CoV S1 protein-immunized rabbits. Additionally, we found that TMPRSS2 promotes SADS-CoV spike-mediated cell entry. Furthermore, we assessed the serum-neutralizing ability of mice vaccinated with rVSV-Venus-SADS SΔ11 using a prime-boost immunization strategy, revealing effective neutralizing antibodies against SADS-CoV infection. In conclusion, we have developed a safe and practical tool for studying SADS-CoV entry and exploring the potential of a recombinant VSV-vectored SADS-CoV vaccine. IMPORTANCE Zoonotic coronaviruses, like swine acute diarrhea syndrome coronavirus (SADS-CoV), pose a continual threat to human and animal health. To combat this, we engineered a safe and efficient tool by modifying the Vesicular Stomatitis Virus (VSV), creating a replication-competent rVSV-Venus-SADS S virus. Through serial passages, we optimized the virus for enhanced membrane anchoring, a key factor in viral propagation. This modified virus, rVSV-Venus-SADS SΔ11, proved susceptible to neutralization, opening avenues for potential vaccines. Additionally, our study revealed the role of TMPRSS2 in SADS-CoV entry. Mice vaccinated with rVSV-Venus-SADS SΔ11 developed potent neutralizing antibodies against SADS-CoV. In conclusion, our work presents a secure and practical tool for studying SADS-CoV entry and explores the promise of a recombinant VSV-vectored SADS-CoV vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
- SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
ORCID-Profile: Zihui Zhu, Rong Zhang, Qiang Ding
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- | Beijing Municipal Natural Science Foundation ()
- Tsinghua University Vanke Special Fund for Public Health and Health Discipline Development
- SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine
- 北京市科学技术委员会 | Beijing Municipal Natural Science Foundation
Zitieren
APA
Zhu, Z., Han, Y., Gong, M., Sun, B., Zhang, R., & Ding, Q. (2024). Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry. Journal of Virology. https://doi.org/10.1128/jvi.01957-23
Vancouver
Zhu Z, Han Y, Gong M, Sun B, Zhang R, Ding Q. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry. Journal of Virology. 2024. doi:10.1128/jvi.01957-23
BibTeX
@article{Zhu2024,
author = {Zhu, Zihui and Han, Yutong and Gong, Mingli and Sun, Bo and Zhang, Rong and Ding, Qiang},
title = {Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01957-23}
}
EUVIMED